1996
DOI: 10.1006/faat.1996.0004
|View full text |Cite
|
Sign up to set email alerts
|

Effect of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) on Influenza Virus Host Resistance in Mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
25
0
1

Year Published

2007
2007
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 112 publications
(26 citation statements)
references
References 39 publications
0
25
0
1
Order By: Relevance
“…For example, with influenza A virus infection AhR activation by the administration of TCDD decreased the survival time to lethal infection and resulted in mortality with a non lethal dose of the virus [42], [43]. The cause of lethality was unclear since TCDD treated animals cleared the virus from the lungs as well as a non treated mice [44]. More than likely animals succumbed to lung pathology associated with increased neutrophilia found in the lungs of TCDD treated mice [21], [45].…”
Section: Discussionmentioning
confidence: 99%
“…For example, with influenza A virus infection AhR activation by the administration of TCDD decreased the survival time to lethal infection and resulted in mortality with a non lethal dose of the virus [42], [43]. The cause of lethality was unclear since TCDD treated animals cleared the virus from the lungs as well as a non treated mice [44]. More than likely animals succumbed to lung pathology associated with increased neutrophilia found in the lungs of TCDD treated mice [21], [45].…”
Section: Discussionmentioning
confidence: 99%
“…Although cellular and molecular mechanisms of TCDD immunotoxicity are not well understood, suppressed humoral and cell-mediated immune responses and decreased host resistance to infectious disease have been observed in experimental animals [1,2]. In particular, several studies indicated that TCDD exposure leads to an enhanced mortality in mice infected with influenza virus [3], increased gene expression of human immunodeficiency virus type-1 (HIV-1) in chronically infected cells [4], and an activation of cytomegalovirus replication in human fibroblasts [5]. Furthermore, TCDD activates HIV-1 replication in OM 10.1 cells, promyelocytic cell line latently infected with HIV-1 [6], and enhances Bovine Herpesvirus type-1 (BHV-1) replication in bovine cells [7].…”
Section: Introductionmentioning
confidence: 97%
“…TCDD causes a broad range of immunologic effects in experimental animals, including decreased host resistance to infectious disease and suppressed humoral and cell-mediated immune responses [4]. In particular, it has been demonstrated that TCDD exposure leads to an enhanced mortality in mice infected with influenza virus [5], increased gene expression of human immunodeficiency virus type-1 (HIV-1) in chronically infected cells [6], and an activation of cytomegalovirus replication in human fibroblasts [7]. Moreover, TCDD activates HIV-1 replication in a promyelocytic cell line latently infected with HIV-1 [8], and enhances BHV-1 replication in a bovine cell line [9].…”
Section: Introductionmentioning
confidence: 99%